Invus Public Equities, LP Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Invus Public Equities, LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Invus Public Equities, LP. Invus Public Equities, LP is Director in LEXICON PHARMACEUTICALS, INC. ($LEXG) and 10% Owner in Seer, Inc. ($SEER) and 10% Owner in Generation Bio Co. ($GBIO).
Latest Insider Trading Transactions of Invus Public Equities, LP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GBIO, LEXG, SEER
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 03 2021 | SEER | Seer, Inc. | Invus Public Equities, L.P. | 10% Owner | Sell | S | 64.15 | 252,545 | 16,201,519 | 5,588,366 | 5.8 M to 5.6 M (-4.32 %) |
Dec 17 2020 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 3.20 | 10,937,500 | 35,000,000 | 32,259,461 | 21.3 M to 32.3 M (+51.30 %) |
Dec 10 2020 | SEER | Seer, Inc. | Invus Public Equities, L.P. | 10% Owner | Option Exercise | C | 0.00 | 249,221 | 0 | 0 | |
Dec 10 2020 | SEER | Seer, Inc. | Invus Public Equities, L.P. | 10% Owner | Option Exercise | C | 0.00 | 474,478 | 0 | 0 | |
Dec 10 2020 | SEER | Seer, Inc. | Invus Public Equities, L.P. | 10% Owner | Option Exercise | C | 0.00 | 373,831 | 0 | 0 | |
Dec 10 2020 | SEER | Seer, Inc. | Invus Public Equities, L.P. | 10% Owner | Option Exercise | C | 0.00 | 3,953,381 | 0 | 0 | |
Dec 10 2020 | SEER | Seer, Inc. | Invus Public Equities, L.P. | 10% Owner | Buy | P | 19.00 | 790,000 | 15,010,000 | 5,840,911 | 5.1 M to 5.8 M (+15.64 %) |
Dec 10 2020 | SEER | Seer, Inc. | Invus Public Equities, L.P. | 10% Owner | Buy | C | 0.00 | 5,050,911 | 0 | 5,050,911 | 0 to 5.1 M |
Jun 18 2020 | GBIO | Generation Bio Co. | Invus Public Equities, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,073,076 | 0 | 0 | |
Jun 18 2020 | GBIO | Generation Bio Co. | Invus Public Equities, L.P. | 10% Owner | Option Exercise | C | 0.00 | 2,186,820 | 0 | 0 | |
Jun 18 2020 | GBIO | Generation Bio Co. | Invus Public Equities, L.P. | 10% Owner | Buy | P | 19.00 | 800,000 | 15,200,000 | 2,814,191 | 2 M to 2.8 M (+39.72 %) |
Jun 18 2020 | GBIO | Generation Bio Co. | Invus Public Equities, L.P. | 10% Owner | Buy | C | 0.00 | 2,014,191 | 0 | 2,014,191 | 0 to 2 M |
Jun 29 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.45 | 57,724 | 718,935 | 3,516,214 | 3.5 M to 3.5 M (+1.67 %) |
Jun 29 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.54 | 125,114 | 1,568,442 | 3,458,490 | 3.3 M to 3.5 M (+3.75 %) |
Jun 26 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.95 | 228,264 | 2,955,083 | 3,333,376 | 3.1 M to 3.3 M (+7.35 %) |
Jun 26 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.36 | 25,461 | 340,090 | 3,105,112 | 3.1 M to 3.1 M (+0.83 %) |
Jun 21 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.27 | 51,600 | 684,613 | 3,079,651 | 3 M to 3.1 M (+1.70 %) |
Jun 21 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.28 | 12,391 | 164,613 | 3,028,051 | 3 M to 3 M (+0.41 %) |
Jun 21 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.45 | 8,982 | 120,819 | 3,015,660 | 3 M to 3 M (+0.30 %) |
Jun 18 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 13.06 | 36,584 | 477,937 | 3,006,678 | 3 M to 3 M (+1.23 %) |
Jun 18 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.66 | 9,200 | 116,462 | 2,970,094 | 3 M to 3 M (+0.31 %) |
Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.83 | 107,023 | 1,373,244 | 2,960,894 | 2.9 M to 3 M (+3.75 %) |
Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.75 | 98,626 | 1,257,452 | 2,853,871 | 2.8 M to 2.9 M (+3.58 %) |
Jun 12 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.89 | 29,747 | 383,427 | 2,755,245 | 2.7 M to 2.8 M (+1.09 %) |
Jun 07 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.93 | 57,439 | 742,508 | 2,725,498 | 2.7 M to 2.7 M (+2.15 %) |
Jun 07 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.58 | 95,079 | 1,196,370 | 2,668,059 | 2.6 M to 2.7 M (+3.70 %) |
Jun 07 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.45 | 173,121 | 2,156,187 | 2,572,980 | 2.4 M to 2.6 M (+7.21 %) |
Jun 04 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.24 | 121,803 | 1,490,576 | 2,399,859 | 2.3 M to 2.4 M (+5.35 %) |
Jun 04 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 12.22 | 147,339 | 1,800,041 | 2,278,056 | 2.1 M to 2.3 M (+6.91 %) |
Jun 04 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 11.62 | 147,339 | 1,712,050 | 2,130,717 | 2 M to 2.1 M (+7.43 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 10.32 | 147,339 | 1,521,025 | 1,983,378 | 1.8 M to 2 M (+8.02 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 10.32 | 147,339 | 1,521,025 | 1,983,378 | 1.8 M to 2 M (+8.02 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.84 | 147,339 | 1,450,420 | 1,836,039 | 1.7 M to 1.8 M (+8.72 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.84 | 147,339 | 1,450,420 | 1,836,039 | 1.7 M to 1.8 M (+8.72 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.62 | 138,700 | 1,334,974 | 1,688,700 | 1.6 M to 1.7 M (+8.95 %) |
May 30 2018 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.62 | 138,700 | 1,334,974 | 1,688,700 | 1.6 M to 1.7 M (+8.95 %) |
Nov 17 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.85 | 50,000 | 492,500 | 1,550,000 | 1.5 M to 1.6 M (+3.33 %) |
Nov 17 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 10.21 | 130,727 | 1,334,396 | 1,500,000 | 1.4 M to 1.5 M (+9.55 %) |
Nov 14 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.47 | 215,133 | 2,037,847 | 1,369,273 | 1.2 M to 1.4 M (+18.64 %) |
Nov 14 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.75 | 215,133 | 2,097,934 | 1,154,140 | 939 K to 1.2 M (+22.91 %) |
Nov 14 2017 | LEXG | LEXICON PHARMACEUT ... | Invus Public Equities, L.P. | Director | Buy | P | 9.74 | 145,680 | 1,418,384 | 939,007 | 793.3 K to 939 K (+18.36 %) |
Page: 1